Medicine Approved which Claims to Fight Mild Corona Patients
- by Satakshi-Gauri
- Jun 25, 2020 13:03
The whole world is fighting against COVID-19 and its bizarre consequences. Each day the number of patients is increasing rapidly and research is being done all over the world to find out the cure or medicine for this deadly virus. Some medicines and vaccines even claimed earlier that they could fight and cure the virus, but none of them worked. People are becoming impatient to get back to their normal lives, but yet there is nothing that can treat the virus. There is no specific medicine that can cure the virus to date. India has authorised off-label use of tocilizumab and convalescent plasma therapy on specific groups of patients.
Hydroxychloroquine, an antimalarial drug also claimed to be effective to cure this virus. It is proven that it does not results reduction in the mortality rate of infected patients. Where, Glenmark has received approval to manufacture and market Favipiravir in India for mild to moderate COVID-19 cases. It is a prescription-based medicine. The price of this tablet will be ₹103 per tablet, the prescription-based drug will be available as a 200 mg tablet at an MRP of ₹3,500 for a strip of 34 tablets. There are still researches going on all over the globe and many other pharmaceutical companies are bringing up medicines or drugs to get rid of this pandemic. Let's stay home for a while, stay positive, and hope for the best. Frontline forces are fighting day and night to keep us safe, keep co-operating, and keep the best care of your body and environment.
Read More Latest Bollywood Movie Reviews & News
Read More Sports News, Cricket News
Read More Latest Mobile, Laptop News & Review